active: true
branding:
    icon_url: https://api.polygon.io/v1/reference/company-branding/cWlhZ2VuLmNvbQ/images/2025-04-04_icon.jpeg
    logo_url: https://api.polygon.io/v1/reference/company-branding/cWlhZ2VuLmNvbQ/images/2025-04-04_logo.svg
cik: 0001015820
currency_name: usd
description: Qiagen offers proprietary sample and assay technology to extract, purify,
    amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost
    evenly between applications in life sciences and molecular diagnostics. Qiagen
    generates nearly 90% of its revenue from consumables with the balance coming from
    instrumentation and related services. The Americas account for the largest portion
    of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific
    (16%).
homepage_url: https://www.qiagen.com
list_date: '1996-06-28'
locale: us
market: stocks
market_cap: 10674751062.869999
name: QIAGEN N.V.
primary_exchange: XNYS
round_lot: 100
ticker: QGEN
ticker_root: QGEN
total_employees: 5700
type: CS
weighted_shares_outstanding: 216834269
